PublicationEMA

Regulatory Approval and Market Access: a winning combination for drug launch optimization

Having a combined regulatory and market access strategy is critical for a drug launch to be successful.

Marcus Deans, Mark A De Rosch and Emmanuelle Voisin

Download the full publication now

Fill in the form to download the content

*I have read and agreed to the Terms of Use and the Privacy Policy.Yes, I would like to receive communications regarding VCLS services and events

Emmanuelle M. Voisin, PhD

Founder and CEO

Dr. Emmanuelle Voisin founded Voisin Consulting Life Sciences (VCLS) in 1997. The firm has become a leading advisor to Biotech,…

View profile

Marcus Deans

Vice President Market Access & Pricing

Mark De Rosch

Vice President Head of US Operations